Skip to content
Relatix Health

Relatix Health

Radically different

  • Participate
    • Start here
  • Services
    • Tests to participate in
  • Resources
  • About
    • Our Vision – A radically different future
    • Our mission – personalised lifelong support
    • News
    • FAQ
    • Contact
    • Trust and Privacy
    • Support us
  • Log in / Sign up
Posted on June 12, 2026 by admin

Investigating the Efficacy and Mechanisms of Individualized tACS Targeting Anhedonia in Late-Life Depression

Conditions: Late-Life Depression; Anhedonia

Interventions: Device: Transcranial Alternating Current Stimulation (tACS); Device: shame tACS

Sponsors: Jie Li

Recruiting
CategoriesClinicalTrials.gov TagsDepression, Medical device, Mood and emotional regulation, News Approved

Post navigation

Previous PostPrevious Laser‑Driven Phase Contrast Enhances Cryo‑EM Resolution of Small Proteins
Next PostNext A Pilot Randomized Controlled Trial of a Mental Fitness Intervention for Anesthesiology Resident Wellbeing and Self-Compassion
Relatix Health

Relatix Health helps people understand their minds, explore relevant support and take part in research on their own terms. We connect lived experience with responsible research while protecting privacy, dignity and choice.

For researchers, clinicians and organisations, visit our sister site, Relatix Bio.

Take part

Start here Participate Tests to participate in Log in or sign up

Find support

Resources Services FAQ I need help now

Our commitments

Our Vision Our Mission Trust and Privacy

About

About us News Support us Contact

© 2026 Relatix Health. All rights reserved.